Gurpreet Deol-Bhullar

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

X. Montalban, L. Kappos, P. Vermersch, 2018, Annals of neurology.

Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial

X. Montalban, L. Kappos, P. Vermersch, 2017, Journal of Neurology, Neurosurgery & Psychiatry.

Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial.

D. Murphy, E. Anagnostou, J. Veenstra-VanderWeele, 2022, The lancet. Psychiatry.